Exact Mass: 562.2307884
Exact Mass Matches: 562.2307884
Found 117 metabolites which its exact mass value is equals to given mass value 562.2307884
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
1-(4-(5-Maleimidopentyl)aminobenzyl)ethylenediaminetetraacetic acid
3,3-Dihydroxy-5-methoxy-2,5,6-tris(4-hydroxybenzyl)bibenzyl
(19Z)-burnamine-17-O-3,4,5-trimethoxybenzoate|19(Z)-burnamine-17-O-3,4,5-trimethoxybenzoate|burnamine-17-O-3,4,5-trimethoxybenzoate
C31H34N2O8 (562.2315044000001)
(20R,22R)-15alpha-acetoxy-5alpha-chloro-16beta,17beta-epoxy-6beta,14beta-dihydroxy-1-oxo-witha-2,24-dienolide|physagulin I
3,3-dihydroxy-5-methoxy-2,6,6-tri(p-hydroxybenzyl)bibenzyl|pleiobibenzynin A
3,3-dihydroxy-5-methoxy-2,4,6-tri(4-hydroxybenzyl)bibenzyl
Cys Phe Phe Phe
Asp Asp Lys Trp
Asp Asp Trp Lys
Asp Lys Asp Trp
Asp Lys Trp Asp
Asp Trp Asp Lys
Asp Trp Lys Asp
Glu Phe His Met
C25H34N6O7S (562.2209574000001)
Glu Phe Met His
C25H34N6O7S (562.2209574000001)
Glu His Phe Met
C25H34N6O7S (562.2209574000001)
Glu His Met Phe
C25H34N6O7S (562.2209574000001)
Glu Met Phe His
C25H34N6O7S (562.2209574000001)
Glu Met His Phe
C25H34N6O7S (562.2209574000001)
Glu Gln Thr Trp
Glu Gln Trp Thr
Glu Thr Gln Trp
Glu Thr Trp Gln
Glu Trp Gln Thr
Glu Trp Thr Gln
Phe Cys Phe Phe
Phe Glu His Met
C25H34N6O7S (562.2209574000001)
Phe Glu Met His
C25H34N6O7S (562.2209574000001)
Phe Phe Cys Phe
Phe Phe Phe Cys
Phe His Glu Met
C25H34N6O7S (562.2209574000001)
Phe His Met Glu
C25H34N6O7S (562.2209574000001)
Phe Met Glu His
C25H34N6O7S (562.2209574000001)
Phe Met His Glu
C25H34N6O7S (562.2209574000001)
His Glu Phe Met
C25H34N6O7S (562.2209574000001)
His Glu Met Phe
C25H34N6O7S (562.2209574000001)
His Phe Glu Met
C25H34N6O7S (562.2209574000001)
His Phe Met Glu
C25H34N6O7S (562.2209574000001)
His Met Glu Phe
C25H34N6O7S (562.2209574000001)
His Met Phe Glu
C25H34N6O7S (562.2209574000001)
Lys Asp Asp Trp
Lys Asp Trp Asp
Lys Trp Asp Asp
Met Glu Phe His
C25H34N6O7S (562.2209574000001)
Met Glu His Phe
C25H34N6O7S (562.2209574000001)
Met Phe Glu His
C25H34N6O7S (562.2209574000001)
Met Phe His Glu
C25H34N6O7S (562.2209574000001)
Met His Glu Phe
C25H34N6O7S (562.2209574000001)
Met His Phe Glu
C25H34N6O7S (562.2209574000001)
Gln Glu Thr Trp
Gln Glu Trp Thr
Gln Thr Glu Trp
Gln Thr Trp Glu
Gln Trp Glu Thr
Gln Trp Thr Glu
Thr Glu Gln Trp
Thr Glu Trp Gln
Thr Gln Glu Trp
Thr Gln Trp Glu
Thr Trp Glu Gln
Thr Trp Gln Glu
Trp Asp Asp Lys
Trp Asp Lys Asp
Trp Glu Gln Thr
Trp Glu Thr Gln
Trp Lys Asp Asp
Trp Gln Glu Thr
Trp Gln Thr Glu
Trp Thr Glu Gln
Trp Thr Gln Glu
bis-(4-dimethylamino-phenyl)-phenyl-d5-carbenium picrate
Otilonium Bromide
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D005765 - Gastrointestinal Agents Otilonium bromide (OB) is an orally active mAChR inhibitor and smooth muscle relaxant which can interfere with the mobilization of calcium in intestinal smooth muscle, OB can be used for research of irritable bowel syndrome[1][2][3].
Zinc,bis[3,5-bis(1,1-dimethylethyl)-2-(hydroxy-kO)benzoato-kO]-, (T-4)-
[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-[(2R,4R)-2-(4-hydroxybutoxy)-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyran-6-yl]methanone
C29H33F3N2O6 (562.2290594000001)
[(1S)-7-methoxy-1-(4-methoxyphenyl)sulfonyl-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
[(1R)-7-methoxy-1-(4-methoxyphenyl)sulfonyl-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
SCH529074
SCH529074 is a potent and orally active p53 activator. SCH529074 binds specifically and conformation-dependently to p53 DBD ( DNA binding domain) with a Ki of 1-2 μM in a saturable manner. SCH529074 restores mutant p53 function and interrupts HDM2-mediated ubiquitination of wild Type p53. SCH529074 can be used for the study of non-small-cell lung carcinoma (NSCLC)[1][2].
3-[2-(3-hydroxyphenyl)ethyl]-2,4,6-tris[(4-hydroxyphenyl)methyl]-5-methoxyphenol
5-[(2r,3s)-7-hydroxy-2-(hydroxymethyl)-4-(prop-2-en-1-yl)-6-[4-(prop-2-en-1-yl)phenoxy]-2,3-dihydro-1-benzofuran-3-yl]-5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol
methyl 5-methoxy-12-[1-(7-methoxy-2h-1,3-benzodioxole-5-carbonyloxy)ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C31H34N2O8 (562.2315044000001)
methyl 14-ethylidene-19-[(3,4,5-trimethoxybenzoyloxy)methyl]-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
C31H34N2O8 (562.2315044000001)
5-[7-hydroxy-2-(hydroxymethyl)-4-(prop-2-en-1-yl)-6-[4-(prop-2-en-1-yl)phenoxy]-2,3-dihydro-1-benzofuran-3-yl]-5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol
(1s,4as,6s,7r,7as)-4-({[(2r,3r,4s,5s,6r)-3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-[(acetyloxy)methyl]-6,7-dihydroxy-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(1s,4as,6s,7r,7as)-6-(acetyloxy)-7-[(acetyloxy)methyl]-7-hydroxy-4-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
4-({[3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-[(acetyloxy)methyl]-6,7-dihydroxy-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
3-[1-hydroxy-7-(6-{7-hydroxy-7-[2-hydroxy-5-(hydroxymethyl)-4-oxo-5h-pyrrol-3-ylidene]hepta-1,3,5-trien-1-yl}cyclohex-2-en-1-yl)hepta-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione
C31H34N2O8 (562.2315044000001)
(1s,4as,6s,7r,7as)-6-(acetyloxy)-4-({[(2r,3r,4s,5s,6r)-3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-hydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(1r,2s,3s,4s,6r,7s,10s,11s,16r,17r)-16-chloro-6-[(1r)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,17-dihydroxy-7,11-dimethyl-12-oxo-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadec-13-en-3-yl acetate
methyl (1r,12r,19r)-5-methoxy-12-[(1s)-1-(7-methoxy-2h-1,3-benzodioxole-5-carbonyloxy)ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C31H34N2O8 (562.2315044000001)
(1s,4as,6s,7r,7as)-6-(acetyloxy)-7-[(acetyloxy)methyl]-7-hydroxy-4-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
3-(2-{5-hydroxy-2-[(4-hydroxyphenyl)methyl]phenyl}ethyl)-2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxyphenol
methyl (1r,9s,11s,15s,17s,19r)-14-ethylidene-19-[(3,4,5-trimethoxybenzoyloxy)methyl]-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
C31H34N2O8 (562.2315044000001)
16-chloro-6-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-2,17-dihydroxy-7,11-dimethyl-12-oxo-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadec-13-en-3-yl acetate
6-(acetyloxy)-7-[(acetyloxy)methyl]-7-hydroxy-4-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(2r)-1-(2-hydroxy-3,5-dimethyl-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-{[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-2-methylbutan-1-one
methyl (1r,9s,11s,14z,15s,17s,19r)-14-ethylidene-19-[(3,4,5-trimethoxybenzoyloxy)methyl]-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
C31H34N2O8 (562.2315044000001)
3-(2-{3-hydroxy-4-[(4-hydroxyphenyl)methyl]phenyl}ethyl)-2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxyphenol
(2r)-1-[2-hydroxy-3,5-dimethyl-4,6-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phenyl]-2-methylbutan-1-one
6-(acetyloxy)-4-({[3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-hydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
3-(2-{2-hydroxy-5-[(4-hydroxyphenyl)methyl]phenyl}ethyl)-2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxyphenol
3-(2-{3-hydroxy-5-[(4-hydroxyphenyl)methyl]phenyl}ethyl)-2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxyphenol
(3e,5s)-3-[(2e,4e,6e)-1-hydroxy-7-[(1s,6s)-6-[(1e,3e,5e)-7-hydroxy-7-[(3z,5s)-2-hydroxy-5-(hydroxymethyl)-4-oxo-5h-pyrrol-3-ylidene]hepta-1,3,5-trien-1-yl]cyclohex-2-en-1-yl]hepta-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione
C31H34N2O8 (562.2315044000001)